ScholarIQanswers from OpenAlex

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.

PaperCitations, authors & open-access status

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. have?

ScholarIQcitation count

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. has 59 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. published?

ScholarIQyear

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. has 2019 year in the ScholarIQ index.

What is the open-access status of Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.?

ScholarIQoa status

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. has closed oa status in the ScholarIQ index.

What is the PMID of Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.?

ScholarIQpmid

The PMID for Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. is on the source record.

What is the OpenAlex record for Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.?

ScholarIQopenalex

The OpenAlex for Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial